e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Asthma drugs: new findings
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The impact of the addition of omalizumab on the utilization of healthcare resources by severe persistent asthma patients
S. Dyer, S. Packham, S. Davies (Swansea, United Kingdom)
Source:
Annual Congress 2013 –Asthma drugs: new findings
Session:
Asthma drugs: new findings
Session type:
Thematic Poster Session
Number:
4122
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Dyer, S. Packham, S. Davies (Swansea, United Kingdom). The impact of the addition of omalizumab on the utilization of healthcare resources by severe persistent asthma patients. Eur Respir J 2013; 42: Suppl. 57, 4122
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Dedicated severe asthma services improve healthcare utilisation and quality of life
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013
The impact of telemedicine in healthcare demand by patients with severe persistent asthma
Source: International Congress 2016 – Abstracts in medical education, the web and the internet
Year: 2016
Feasibility and acceptability of group-CBT for people with severe asthma
Source: Annual Congress 2013 –The kaleidoscope of respiratory nursing
Year: 2013
Patients’ evaluation on asthma severity was related to level of asthma control and quality of life over seven years follow-up
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013
Predictors of respiratory health status in patients with severe asthma
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016
The prevalence of comorbidities in COPD patients and their impact on quality of life and COPD symptoms in primary care patients - An UNLOCK study from the IPCRG
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Association of asthma admissions and health related quality of life (HRQoL), asthma control and severity
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Effects of allergic rhinitis on self-management and quality of life in adult patients with asthma
Source: International Congress 2014 – From individual patient interactions to models of care: the nursing perspective
Year: 2014
Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Effect of an individualized education program on asthma control and health-related quality of life in adult asthma patients: A prospective study
Source: International Congress 2016 – Abstracts in medical education, the web and the internet
Year: 2016
COPD medication adherence and quality of life
Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care
Year: 2016
Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
One year dynamics of life quality depending on the adherence to therapy in patients with bronchial asthma
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013
Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Developing integrated mental health and asthma treatment protocol using quality improvement methods
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
How does asthma affect the day-to-day life of sufferers?
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015
An economic evaluation of a self-management programme for patients with COPD
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015
Relationship between guideline treatment and health-related quality of life in asthma
Source: Eur Respir J 2004; 23: 718-722
Year: 2004
Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept